
scopis
AI-driven healthcare analytics platform designed to enhance clinical insights and improve patient outcomes.
Cutting-edge surgical AR navigation now embedded in Stryker's portfolio — enterprise medical device, not a SaaS tool.
Scopis — AR-guided surgical navigation system for ENT, spine, and craniofacial surgery, now part of Stryker.
Scopis was a Berlin-based medical AR and hybrid navigation company acquired by Stryker in November 2017. Its technology — optical/electromagnetic tracking overlaid with augmented-reality guidance via Microsoft HoloLens — lives on as Stryker's ENT Navigation System and Target Guided Surgery platform. The DB mislabels it as an 'AI-driven healthcare analytics platform' in the 'Developer & Technical' category with a free trial; in reality it is FDA-cleared enterprise surgical-navigation hardware and software sold exclusively through institutional Stryker procurement at custom pricing.
Scopis pioneered mixed-reality surgical navigation and earned FDA 510(k) and Health Canada clearance. With Stryker's distribution and support infrastructure, the technology reaches major medical centers worldwide — a genuine clinical differentiator for complex surgeries.
No longer available as a standalone product; fully absorbed into Stryker's sales channel since 2017. The independent scopis.com domain is defunct. Evaluation requires going through Stryker's enterprise sales process.
A look inside
Frequently Asked Questions
Alternatives
Stryker Q Guidance System for advanced spinal robotics and navigation.
Medtronic StealthStation for lower-cost EM-only ENT/neurosurgery navigation.
Tags
Explore related categories
Conversion Gems independently reviews every tool. We may earn a commission if you sign up through our links — it never affects our verdict or ranking.

